These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10652368)

  • 1. Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice.
    Choi J; Liu RM; Kundu RK; Sangiorgi F; Wu W; Maxson R; Forman HJ
    J Biol Chem; 2000 Feb; 275(5):3693-8. PubMed ID: 10652368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of glutathione synthetic enzymes by acidic fibroblast growth factor.
    Choi J; Opalenik SR; Wu W; Thompson JA; Forman HJ
    Arch Biochem Biophys; 2000 Mar; 375(1):201-9. PubMed ID: 10683268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione depletion associated with the HIV-1 TAT protein mediates the extracellular appearance of acidic fibroblast growth factor.
    Opalenik SR; Ding Q; Mallery SR; Thompson JA
    Arch Biochem Biophys; 1998 Mar; 351(1):17-26. PubMed ID: 9501919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cystine-glutamate transporter xc- by human immunodeficiency virus type 1 transactivator protein tat in retinal pigment epithelium.
    Bridges CC; Hu H; Miyauchi S; Siddaramappa UN; Ganapathy ME; Ignatowicz L; Maddox DM; Smith SB; Ganapathy V
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2906-14. PubMed ID: 15326101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice.
    Prakash O; Tang ZY; He YE; Ali MS; Coleman R; Gill J; Farr G; Samaniego F
    J Natl Cancer Inst; 2000 May; 92(9):721-8. PubMed ID: 10793108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 Tat protein impairs selenoglutathione peroxidase expression and activity by a mechanism independent of cellular selenium uptake: consequences on cellular resistance to UV-A radiation.
    Richard MJ; Guiraud P; Didier C; Seve M; Flores SC; Favier A
    Arch Biochem Biophys; 2001 Feb; 386(2):213-20. PubMed ID: 11368344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.
    Zeng Y; Zhang X; Huang Z; Cheng L; Yao S; Qin D; Chen X; Tang Q; Lv Z; Zhang L; Lu C
    J Virol; 2007 Mar; 81(5):2401-17. PubMed ID: 17151125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline.
    Kim BO; Liu Y; Ruan Y; Xu ZC; Schantz L; He JJ
    Am J Pathol; 2003 May; 162(5):1693-707. PubMed ID: 12707054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells.
    Price TO; Ercal N; Nakaoke R; Banks WA
    Brain Res; 2005 May; 1045(1-2):57-63. PubMed ID: 15910762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
    Hyun TS; Subramanian C; Cotter MA; Thomas RA; Robertson ES
    J Virol; 2001 Sep; 75(18):8761-71. PubMed ID: 11507221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tat-induced lesions in transgenic mice do not correlate with the HIV-1 LTR transactivation.
    Fergelot P; Molina T; Blanchet P; Grimber G; Duquenne O; Couton D; Zider A; Briand P; Cavard C
    C R Acad Sci III; 1995 Mar; 318(3):329-37. PubMed ID: 7788501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron chelation decreases human immunodeficiency virus-1 Tat potentiated tumor necrosis factor-induced NF-kappa B activation in Jurkat cells.
    Shatrov VA; Boelaert JR; Chouaib S; Dröge W; Lehmann V
    Eur Cytokine Netw; 1997 Mar; 8(1):37-43. PubMed ID: 9110146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hematopoietic progenitor cell proliferation by ethanol in human immunodeficiency virus type 1 tat-expressing transgenic mice.
    Prakash O; Rodriguez VE; Tang ZY; Zhou P; Coleman R; Dhillon G; Shellito JE; Nelson S
    Alcohol Clin Exp Res; 2001 Mar; 25(3):450-6. PubMed ID: 11290858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of lymphoid hyperplasia in transgenic mice expressing the HIV tat gene.
    Vellutini C; Horschowski N; Philippon V; Gambarelli D; Nave KA; Filippi P
    AIDS Res Hum Retroviruses; 1995 Jan; 11(1):21-9. PubMed ID: 7537511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 Tat protein in tumour cell lines derived from BK virus/tat-transgenic mice.
    Rusnati M; Coltrini D; Campioni D; Tanghetti E; Corallini A; Barbanti-Brodano G; Giuliani R; Gibellini D; Presta M
    AIDS; 1997 May; 11(6):727-36. PubMed ID: 9143604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat.
    Guo HG; Pati S; Sadowska M; Charurat M; Reitz M
    J Virol; 2004 Sep; 78(17):9336-42. PubMed ID: 15308728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular Tat.
    Rusnati M; Taraboletti G; Urbinati C; Tulipano G; Giuliani R; Molinari-Tosatti MP; Sennino B; Giacca M; Tyagi M; Albini A; Noonan D; Giavazzi R; Presta M
    FASEB J; 2000 Oct; 14(13):1917-30. PubMed ID: 11023976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human immunodeficiency virus type I Tat protein potentiates ethanol-induced neutrophil functional impairment in transgenic mice.
    Prakash O; Zhang P; Xie M; Ali M; Zhou P; Coleman R; Stoltz DA; Bagby GJ; Shellito JE; Nelson S
    Alcohol Clin Exp Res; 1998 Dec; 22(9):2043-9. PubMed ID: 9884149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody spectrum against the viral transactivator protein in patients with human immunodeficiency virus type 1 infection and Kaposi's sarcoma.
    Demirhan I; Chandra A; Mueller F; Mueller H; Biberfeld P; Hasselmayer O; Chandra P
    J Hum Virol; 2000; 3(3):137-43. PubMed ID: 10881993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription.
    Harrod R; Nacsa J; Van Lint C; Hansen J; Karpova T; McNally J; Franchini G
    J Biol Chem; 2003 Apr; 278(14):12310-8. PubMed ID: 12501250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.